{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T01:54:58Z","timestamp":1698630898852},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T00:00:00Z","timestamp":1285977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T00:00:00Z","timestamp":1285977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11894-010-0142-z","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T05:26:53Z","timestamp":1285910813000},"page":"502-506","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preparing the Patient for Immunosuppressive Therapy"],"prefix":"10.1007","volume":"12","author":[{"given":"Sunanda","family":"Kane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,2]]},"reference":[{"key":"142_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","volume":"134","author":"M Toruner","year":"2008","unstructured":"Toruner M, Loftus EV Jr, Harmsen WS, et al.: Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134:929\u2013936.","journal-title":"Gastroenterology"},{"key":"142_CR2","doi-asserted-by":"crossref","unstructured":"\u2022 Marehbian J, Arrighi HM, Hass S, et al.: Adverse events associated with common therapy regimens for moderate-to-severe Crohn\u2019s disease. Am J Gastroenterol 2009, 104:2524\u20132533. This article provides a nice review of infectious and neoplastic complications with common therapies used to treat Crohn\u2019s disease.","DOI":"10.1038\/ajg.2009.322"},{"key":"142_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","volume":"4","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al.: Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621\u2013630.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"142_CR4","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.gastro.2006.01.047","volume":"130","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Abreu MT, Cohen R, Tremaine W: American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006, 130:935\u2013939.","journal-title":"Gastroenterology"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","volume":"105","author":"A Kornbluth","year":"2010","unstructured":"Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology: Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010, 105:501\u2013523.","journal-title":"Am J Gastroenterol"},{"key":"142_CR6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ajg.2008.168","volume":"104","author":"GR Lichtenstein","year":"2009","unstructured":"Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology: Management of Crohn\u2019s disease in adults. Am J Gastroenterol 2009, 104:465\u2013483","journal-title":"Am J Gastroenterol"},{"key":"142_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1365-2036.2006.03092.x","volume":"24","author":"SV Kane","year":"2006","unstructured":"Kane SV, Dixon LJ: Adherence rates with infliximab therapy in Crohn\u2019s disease. Aliment Pharmacol Ther 2006, 24:1099\u20131103.","journal-title":"Aliment Pharmacol Ther"},{"key":"142_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/PPA.S5835","volume":"3","author":"JL Barton","year":"2009","unstructured":"Barton JL: Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence 2009, 3:335\u2013344.","journal-title":"Patient Prefer Adherence"},{"key":"142_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ibd.20944","volume":"15","author":"M Moscandrew","year":"2009","unstructured":"Moscandrew M, Mahadevan U, Kane S: General health maintenance in IBD. Inflamm Bowel Dis 2009, 15:1399\u20131409.","journal-title":"Inflamm Bowel Dis"},{"key":"142_CR10","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","volume":"101","author":"GY Melmed","year":"2006","unstructured":"Melmed GY, Ippoliti AF, Papadakis KA, et al.: Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006, 101:1834\u20131840.","journal-title":"Am J Gastroenterol"},{"key":"142_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ajg.2009.523","volume":"105","author":"GY Melmed","year":"2010","unstructured":"Melmed GY, Agarwal N, Frenck RW, et al.: Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol 2010, 105:148\u2013154.","journal-title":"Am J Gastroenterol"},{"key":"142_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/jama.239.1.45","volume":"239","author":"JK Keene","year":"1978","unstructured":"Keene, JK, Lowe DK, Grosfeld JL, et al.: Disseminated varicella complicating ulcerative colitis. JAMA 1978, 239:45\u201346.","journal-title":"JAMA"},{"key":"142_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2133.2008.08851.x","volume":"159","author":"S Domm","year":"2008","unstructured":"Domm S, Cinatl J, Mrowietz U: The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol 2008, 159:1217\u20131228.","journal-title":"Br J Dermatol"},{"key":"142_CR14","unstructured":"Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices: Adult immunization schedule for 2010. Available at http:\/\/www.cdc.gov.vaccines\/recs\/schedules\/adult-schedule.htm. Accessed August 2010."},{"key":"142_CR15","doi-asserted-by":"crossref","unstructured":"\u2022 Wasan SK, Baker SE, Skolnik PR, Farraye FA: A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 2010, 105:1231\u20131238. This article is an up-to-date, evidence-based guide to vaccinations for the patient with IBD.","DOI":"10.1038\/ajg.2009.733"},{"key":"142_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","volume":"8","author":"MD Long","year":"2010","unstructured":"Long MD, Herfarth HH, Pipkin CA, et al.: Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2010, 8:268\u2013274.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"142_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","volume":"103","author":"S Kane","year":"2008","unstructured":"Kane S, Khatibi B, Reddy D: Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008, 103:631\u2013636.","journal-title":"Am J Gastroenterol"},{"key":"142_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.gastro.2008.10.021","volume":"136","author":"H Singh","year":"2009","unstructured":"Singh H, Demers AA, Nugent Z, et al.: Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study. Gastroenterology 2009, 136:451\u2013458.","journal-title":"Gastroenterology"},{"key":"142_CR19","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1001\/jama.2009.880","volume":"301","author":"JA Kovacs","year":"2009","unstructured":"Kovacs JA, Masur H: Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA 2009, 301:2578\u20132585.","journal-title":"JAMA"},{"key":"142_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cgh.2005.10.014","volume":"4","author":"CN Bernstein","year":"2006","unstructured":"Bernstein CN: Osteoporosis in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006, 4:152\u20131526.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1155\/2009\/201430","volume":"23","author":"DC Sadowski","year":"2009","unstructured":"Sadowski DC, Bernstein CN, Bitton A, et al.; and the CAG Crohn\u2019s Consensus Group: Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn\u2019s disease. Can J Gastroenterol 2009, 23:185\u2013202.","journal-title":"Can J Gastroenterol"},{"key":"142_CR22","doi-asserted-by":"crossref","unstructured":"\u2022 Papa A, Mocci G, Bonizzi M, et al.: Use of infliximab in particular clinical settings: management based on current evidence. Am J Gastroenterol 2009, 104:1575\u20131586. This article provides an updated review of the use of infliximab in clinical practice.","DOI":"10.1038\/ajg.2009.162"},{"key":"142_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tube.2008.12.004","volume":"89","author":"S Murakami","year":"2009","unstructured":"Murakami S, Takeno M, Kirino Y, et al.: Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis 2009, 89:136\u2013141.","journal-title":"Tuberculosis"},{"key":"142_CR24","unstructured":"Remicade [package insert]. Malvern PA: Centocor Biotech; 2010."},{"key":"142_CR25","unstructured":"Humira [package insert]. Abbott Park IL: Abbott Laboratories; 2010."},{"key":"142_CR26","unstructured":"Cimzia [package insert]. Smyrna GA: UCB; 2009."},{"key":"142_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00004836-200208000-00007","volume":"35","author":"JH Rubenstein","year":"2002","unstructured":"Rubenstein JH, Chong RY, Cohen RD: Infliximab decreases resource use among patients with Crohn\u2019s disease. J Clin Gastroenterol 2002 35:151\u2013156.","journal-title":"J Clin Gastroenterol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-010-0142-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0142-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-010-0142-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:07:21Z","timestamp":1659089241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-010-0142-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,2]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1007\/s11894-010-0142-z","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,2]]},"assertion":[{"value":"2 October 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}